Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of dopamine receptor modulators, which may aid in treating conditions like Parkinson’s disease and schizophrenia. Its structural features support binding affinity and selectivity toward specific CNS receptors, making it valuable in medicinal chemistry for optimizing lead compounds. Also employed in structure-activity relationship (SAR) studies to enhance potency and reduce off-target effects in neuroactive drug candidates.